UnitedHealth (UNH) delayed its earnings report amid rising medical costs and is now set to report second quarter results on Tuesday. Meanwhile, Sarepta (SRPT) is facing FDA scrutiny after drug-related deaths. Yahoo Finance Senior Reporter Anjalee Khemlani breaks down UnitedHealth’s earnings outlook and Sarepta’s ongoing drug investigation. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
